Home
Who we are
Who we are
Overview
Chairman's Profile
Board of Directors
Team Wockhardt
Collaborations / Partnerships
Faclities
Manufacturing
Contract Manufacturing
Virtual Tour
Global Presence
Our Footprints
Other websites
Community Care
Wockhardt Foundation
We touch lives
R & D
Overview
Generics
New Drug Discovery
Biotechnology
Overview
Biopharmaceuticals
Biotechnology Park
Gallery
Corporate Regulatory
Marketing & Regulatory Infrastructure
Products
Search Products
People
Frequently Asked Questions
Life at Wockhardt
Focus on Development
Wockhardt Anthem
Meet our People
Wockhardt on LinkedIn
Career Openings
Investors
Financials at a glance
Annual Reports
AGM Notice
Chairman's AGM Speeches
Other Shareholders Services
Quarterly Results
Financial Press Releases
Chairman's letter to Shareowners
Details of Unclaimed Dividend
Filings with Stock Exchange
Shareholding Pattern
Stock Quotes
Statutory Communication
Policies
Credit Rating
Investor Communication
Investor Meet
Investor Contact
Investor Call
Accounts of Subsidiaries
Media & Press
Media coverage
Press Release
Media Kit
Media Contact
CSR
CSR Policy
Report on CSR activities – Wockhardt Foundation
CSR Strategy
Quarterly Report
Stakeholders Engagement
Home
>
Media
>
Press Releases
Press Releases
Wockhardt Press Releases
Archives
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
1
2
3
Wockhardt and Serum Life Sciences UK announce collaboration for manufacturing multiple vaccines in the United Kingdom
20 March, 2022
National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt’s novel once-a-day MDR Gram-negative antibiotic WCK 6777
16 March, 2022
Wockhardt gets CDSCO nod for exporting up to 100 million doses of Sputnik Vaccines
08 February, 2022
Q3 (Oct-Dec 2021) Financial Results FY22
27 January, 2022
Q2 (Jul-Sept 2021) Financial Results FY22
08 November, 2021
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
26 August, 2021
RDIF and Wockhardt partner to produce Sputnik V and Sputnik Light vaccines against COVID-19
13 August, 2021
Hugely successful vaccination roll out made possible by UK - Indian business partnership
27 July, 2021
Q1 (Apr-Jun 2021) Financial Results FY22
22 July, 2021
Wockhardt UK proudly hosts visit of HRH The Prince of Wales
05 July, 2021
1
2
3